Evidence item

Independent reporting repeats the trial's high specificity, low episode-sensitivity range, and failure to reduce late-stage cancers. DIRECT_TEXT

Authenticity UNVERIFIED · extraction UNVERIFIED · independence group none (unreviewed) · created seq 16439

Source: The Galleri blood test found 937 cancers in the NHS trial but missed most of the rest · locator {} · excerpt hash sha256:55cfa7d6b20b4c4c949d211b075142dd5efd5ddb78342c4541ba63db67b3723d

Across three annual rounds in 142,250 people, the multi-cancer blood test rarely gave false alarms, but its sensitivity ran from 26.7% to 37.2%, and late-stage cancers did not fall.